Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2549PDF: 1671HTML: 3571Pellagatti Fig 1: 158Pellagatti Fig. 2: 166 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1469PDF: 761HTML: 816 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1688PDF: 957HTML: 431 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3559PDF: 1356HTML: 425Figures . Eliassian: 176 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2422PDF: 731HTML: 5158 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1120HTML: 327PDF: 738 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1465PDF: 1129HTML: 179 -
Pseudo-differentiation syndrome
1189PDF: 597HTML: 10813Figure 1: peripheral blood showing myeloblasts with auer rods: 94Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 83Figure 3: CXR showing pulmonary infiltartes with consolidation: 98Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 80Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 99 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1837PDF: 1438HTML: 332 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3525PDF: 702HTML: 1806 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3278PDF: 2258HTML: 1275 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4520PDF: 1674HTML: 2025 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3467PDF: 1551HTML: 11201Figures Haase: 162 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1731PDF: 667HTML: 662 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3258PDF: 1226HTML: 149 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1450PDF: 852HTML: 121 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1679PDF: 881HTML: 1083Untitled: 118Untitled: 140Untitled: 124Untitled: 129 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3104PDF: 2608HTML: 175 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1617PDF: 813HTML: 343Fig1: 180Fig.2: 205Fig. 3: 139Fig. 5: 146Fig. 4: 179 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2611PDF: 935HTML: 5480 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1134PDF: 520HTML: 2830ATRA induced Reactive Hemophagocytosis: A Case Report: 155 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1620PDF: 741HTML: 10158Figures 1,2,3: 136 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1109PDF: 827Suppl. Files: 415HTML: 207 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7046PDF: 2318HTML: 1641Table 1.: 159Table 2.: 177Table 3.: 158Table 4.: 149 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1115PDF: 795HTML: 1075Coverletter: 152 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3272PDF: 790HTML: 1601figure 1: 133Untitled: 146 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13074PDF: 898HTML: 7254 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1167PDF: 502HTML: 22925 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
1579PDF: 753HTML: 262 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1607PDF: 467HTML: 16943Figure 4: 131Figure 3: 112Figure 2: 107Figure 1: 132 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1101PDF: 694HTML: 96 -
-
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
795PDF: 942Suppl. Files: 535HTML: 60 -







